Interesting that this announcement was marked as market sensitive, whereas the penthrox announcement was not. I've bought mainly on the expansion of the penthrox market, but with the acquisition of avitas respiratory business may have to pay a bit more attention to this side. Lot of people with asthma nowadays.
Ann: FDA Approves New Range of Respiratory Devices, page-8
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 43.0¢ | $141.5K | 317.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 15758 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 402 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |